• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

自组装鲨烯酰阿糖胞苷纳米结构作为治疗白血病疾病的有效纳米药物。

Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.

机构信息

Department of Health Sciences, University Magna Græcia, Catanzaro, Italy.

出版信息

Int J Nanomedicine. 2012;7:2535-46. doi: 10.2147/IJN.S28114. Epub 2012 May 23.

DOI:10.2147/IJN.S28114
PMID:22679366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3367491/
Abstract

BACKGROUND

In this investigation, the antileukemic activity of a new nanomedicine based on the conjugation of 1,1',2-tris-nor-squalenic acid with cytarabine (Ara-C) was evaluated.

METHODS

Squalenoyl-Ara-C conjugate (Sq-Ara-C) self-assembled nanosystems were obtained by the nanoprecipitation method and characterized in vitro and in vivo.

RESULTS

This new nanomedicine, which had a mean diameter of approximately 150 nm, improved the in vitro antitumoral activity of Ara-C in different cancer cell lines (L1210, K562, and MCF-7). Sq-Ara-C nanomedicine allowed reduction of the IC(50) value with respect to the free drug and was also active against drug-resistant leukemic cells (L1210R). A noticeable increase in the survival rate of mice with aggressive metastatic L1210R leukemia was observed after treatment with Sq-Ara-C (50 mg/kg) as compared with the free active compound (100 mg/kg). Finally, evaluation of the biodistribution and pharmacokinetic profiles of the drug demonstrated that these nanoaggregates preferentially localized to the liver and spleen, and protected the drug from physiological metabolism.

CONCLUSION

Squalenoylation of cytarabine offers several pharmacological benefits both in vitro and in vivo.

摘要

背景

在这项研究中，评估了基于 1,1',2-三去甲-squalenic 酸与阿糖胞苷（Ara-C）缀合的新型纳米医学的抗白血病活性。

方法

通过纳米沉淀法获得了 squalenoyl-Ara-C 缀合物（Sq-Ara-C）自组装纳米系统，并对其进行了体外和体内表征。

结果

这种新的纳米医学药物的平均直径约为 150nm，提高了不同癌细胞系（L1210、K562 和 MCF-7）中 Ara-C 的体外抗肿瘤活性。Sq-Ara-C 纳米药物降低了与游离药物相比的 IC50 值，并且对耐药性白血病细胞（L1210R）也具有活性。与游离活性化合物（100mg/kg）相比，用 Sq-Ara-C（50mg/kg）治疗侵袭性转移性 L1210R 白血病小鼠后，观察到生存率明显提高。最后，药物的体内分布和药代动力学评价表明，这些纳米聚集体优先定位于肝脏和脾脏，并保护药物免受生理代谢的影响。

结论

阿糖胞苷的 squalenoylation 提供了体外和体内的多种药理益处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/4b02ec559825/ijn-7-2535f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/fa6eefb515e9/ijn-7-2535f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/56cdd419c986/ijn-7-2535f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/ad9ae2aae217/ijn-7-2535f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/0f9f8af45e5c/ijn-7-2535f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/4b02ec559825/ijn-7-2535f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/fa6eefb515e9/ijn-7-2535f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/56cdd419c986/ijn-7-2535f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/ad9ae2aae217/ijn-7-2535f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/0f9f8af45e5c/ijn-7-2535f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbaa/3367491/4b02ec559825/ijn-7-2535f5.jpg

相似文献

1
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.自组装鲨烯酰阿糖胞苷纳米结构作为治疗白血病疾病的有效纳米药物。
Int J Nanomedicine. 2012;7:2535-46. doi: 10.2147/IJN.S28114. Epub 2012 May 23.
2
Preparation, characterization, and cytotoxicity evaluation of self-assembled nanoparticles of diosgenin-cytarabine conjugate.薯蓣皂苷-阿糖胞苷偶联物自组装纳米粒的制备、表征及细胞毒性评价。
Food Chem Toxicol. 2021 May;151:112101. doi: 10.1016/j.fct.2021.112101. Epub 2021 Mar 5.
3
A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.一种新的吉西他滨纳米药物在敏感和耐药白血病类型中显示出增强的抗癌活性。
J Control Release. 2007 Dec 4;124(1-2):20-7. doi: 10.1016/j.jconrel.2007.08.018. Epub 2007 Aug 23.
4
Squalenoyl nanomedicines as potential therapeutics.角鲨烯酰纳米药物作为潜在的治疗手段。
Nano Lett. 2006 Nov;6(11):2544-8. doi: 10.1021/nl061942q.
5
Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.鲨烯酰吉西他滨纳米药物对60种人类肿瘤细胞系及实验性肿瘤的抗癌疗效。
Mol Pharm. 2009 Sep-Oct;6(5):1526-35. doi: 10.1021/mp900099e.
6
Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.一种新型角鲨烯酰吉西他滨抗癌纳米药物的临床前毒理学（亚急性和急性）及疗效
J Pharmacol Exp Ther. 2008 May;325(2):484-90. doi: 10.1124/jpet.107.133751. Epub 2008 Feb 7.
7
A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.一种由鲨烯酰基-吉西他滨和烷基-溶血磷脂酰乙醇胺组成的独特的多药纳米药物。
Eur J Pharm Biopharm. 2019 Nov;144:165-173. doi: 10.1016/j.ejpb.2019.09.017. Epub 2019 Sep 20.
8
Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.n-鲨烯酰阿糖胞苷的合成及其与磷脂双层膜和单层膜亲和力的评价。
Int J Pharm. 2011 Mar 15;406(1-2):69-77. doi: 10.1016/j.ijpharm.2010.12.038. Epub 2011 Jan 8.
9
Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.新型含紫杉醇衍生物的纳米组装体的合成、表征及生物学评价。
Bioconjug Chem. 2010 Jul 21;21(7):1349-61. doi: 10.1021/bc100154g.
10
A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity.一种具有系统长循环特性和抗癌活性的独特的鲨烯酰化和非聚乙二醇化阿霉素纳米药物。
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):E217-26. doi: 10.1073/pnas.1313459110. Epub 2014 Jan 2.

引用本文的文献

1
Bilosomes and Niosomes for Enhanced Intestinal Absorption and In Vivo Efficacy of Cytarabine in Treatment of Acute Myeloid Leukemia.用于增强阿糖胞苷肠道吸收及体内治疗急性髓系白血病疗效的双分子层脂质体和非离子表面活性剂泡囊
Pharmaceuticals (Basel). 2024 Nov 23;17(12):1572. doi: 10.3390/ph17121572.
2
Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy.用于心脏治疗的创新型多药纳米制剂的研发与表征
Materials (Basel). 2023 Feb 22;16(5):1812. doi: 10.3390/ma16051812.
3
Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities.

本文引用的文献

1
Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway.纳米载体型鲨烯酰基前药促进吉西他滨跨膜扩散：一种全新的药物传递途径。
J Control Release. 2010 Oct 15;147(2):163-70. doi: 10.1016/j.jconrel.2010.07.120. Epub 2010 Aug 5.
2
Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs.基于聚天冬酰肼共聚物的叶酸靶向超分子囊泡聚集体用于抗肿瘤药物的选择性递送。
Biomaterials. 2010 Oct;31(28):7340-54. doi: 10.1016/j.biomaterials.2010.05.060. Epub 2010 Jul 6.
3
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.
核苷转运体与肿瘤微环境中的免疫抑制性腺苷信号：潜在的治疗机会。
Pharmacol Ther. 2022 Dec;240:108300. doi: 10.1016/j.pharmthera.2022.108300. Epub 2022 Oct 22.
4
EtoGel for Intra-Articular Drug Delivery: A New Challenge for Joint Diseases Treatment.用于关节腔内给药的EtoGel：关节疾病治疗的新挑战。
J Funct Biomater. 2021 May 16;12(2):34. doi: 10.3390/jfb12020034.
5
Paclitaxel-loaded sodium deoxycholate-stabilized zein nanoparticles: characterization and cytotoxicity.载有紫杉醇的脱氧胆酸钠稳定的玉米醇溶蛋白纳米颗粒：表征与细胞毒性
Heliyon. 2019 Sep 6;5(9):e02422. doi: 10.1016/j.heliyon.2019.e02422. eCollection 2019 Sep.
6
Sodium deoxycholate-decorated zein nanoparticles for a stable colloidal drug delivery system.用于稳定胶体药物递送系统的脱氧胆酸钠修饰的玉米醇溶蛋白纳米颗粒
Int J Nanomedicine. 2018 Jan 30;13:601-614. doi: 10.2147/IJN.S156930. eCollection 2018.
7
Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.利用纳米粒子克服肿瘤细胞化疗耐药性：溶酶体有利于（硬脂酰）吉西他滨包载固体脂质纳米粒。
Int J Nanomedicine. 2018 Jan 9;13:319-336. doi: 10.2147/IJN.S149196. eCollection 2018.
8
PDE5 Inhibitors-Loaded Nanovesicles: Physico-Chemical Properties and In Vitro Antiproliferative Activity.负载磷酸二酯酶5抑制剂的纳米囊泡：物理化学性质及体外抗增殖活性
Nanomaterials (Basel). 2016 May 18;6(5):92. doi: 10.3390/nano6050092.
9
Nanotechnology applications in hematological malignancies (Review).纳米技术在血液系统恶性肿瘤中的应用（综述）
Oncol Rep. 2015 Sep;34(3):1097-105. doi: 10.3892/or.2015.4100. Epub 2015 Jul 2.
10
Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.壳聚糖/泊洛沙姆188/聚（D，L-丙交酯-共-乙交酯）纳米复合物的物理化学特性及转染特性
Int J Nanomedicine. 2014 May 15;9:2359-72. doi: 10.2147/IJN.S58362. eCollection 2014.
载有吉西他滨的聚乙二醇化的单室脂质体与健择：体内分布、药代动力学特征和体内抗肿瘤活性。
J Control Release. 2010 Jun 1;144(2):144-50. doi: 10.1016/j.jconrel.2010.02.021. Epub 2010 Feb 22.
4
Current and emerging therapies for acute myeloid leukemia.急性髓系白血病的现有和新兴疗法。
Clin Ther. 2009;31 Pt 2:2349-70. doi: 10.1016/j.clinthera.2009.11.017.
5
Squalene: A natural triterpene for use in disease management and therapy.角鲨烯：一种用于疾病管理和治疗的天然三萜烯。
Adv Drug Deliv Rev. 2009 Dec 17;61(15):1412-26. doi: 10.1016/j.addr.2009.09.005. Epub 2009 Oct 2.
6
Conjugation of squalene to acyclovir improves the affinity for biomembrane models.鲨烯与阿昔洛韦缀合可提高对生物膜模型的亲和力。
Int J Pharm. 2009 Dec 1;382(1-2):73-9. doi: 10.1016/j.ijpharm.2009.08.012. Epub 2009 Aug 15.
7
Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.鲨烯酰吉西他滨纳米药物对60种人类肿瘤细胞系及实验性肿瘤的抗癌疗效。
Mol Pharm. 2009 Sep-Oct;6(5):1526-35. doi: 10.1021/mp900099e.
8
Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.鞘内注射脂质体阿糖胞苷（Depocyte）在复发或难治性脑肿瘤儿童及青少年中的安全性和毒性：一项多机构回顾性研究
Anticancer Drugs. 2009 Oct;20(9):794-9. doi: 10.1097/CAD.0b013e32832f4abe.
9
Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase.双氮杂麦角甾醇类化合物，鲨烯环氧化酶抑制剂的抗真菌活性。
Mycoses. 2010 Nov;53(6):481-7. doi: 10.1111/j.1439-0507.2009.01742.x.
10
Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions.鞘内注射脂质体阿糖胞苷治疗急性淋巴细胞白血病脑膜复发的疗效和安全性：两家儿科机构的经验
Leuk Lymphoma. 2008 Aug;49(8):1553-9. doi: 10.1080/10428190802216749.